Pros and Cons of COVID-19 Vaccination in Children: Weighing the Evidence

WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.

Disclosures for additional planners can be found here.

Faculty

Federico Martinón-Torres, MD, PhD

Head of Pediatrics
Director, Translational Pediatrics and Infectious Diseases
Hospital Clínico Universitario de Santiago
Coordinator, Genetics, Vaccines, Infections and Pediatrics Research Group
Healthcare Research Institute of Santiago de Compostela
Santiago de Compostela, Spain

Disclosures

Federico Martinón-Torres, MD, PhD, has the following relevant financial relationships:
Consultant or advisor for: Biofabri; GlaxoSmithKline; Janssen; Medimmune; Merck Sharp & Dohme; Moderna; Novavax; Pfizer; Sanofi
Speaker or member of speakers bureau for: AstraZeneca; GlaxoSmithKline; Merck Sharp & Dohme; Moderna; Pfizer; Sanofi Pasteur; Seqirus
Research funding from: GlaxoSmithKline; Merck Sharp & Dohme; Pfizer; Sanofi
Other: Principal investigator of clinical trials (fees paid to my institution) from Abbott; AstraZeneca; Cubist; GlaxoSmithKline; Medimmune; Merck Sharp & Dohme; Novavax; Pfizer; Regeneron; Roche; Sanofi Pasteur; Seqirus

George Kassianos, CBE, MD (Hons), FRCGP

General Practitioner
National Immunisation Lead
Royal College of General Practitioners
President, British Global and Travel Health Association
London, United Kingdom

Disclosures

George Kassianos, CBE, MD (Hons), FRCGP, has the following relevant financial relationships:
Consultant or advisor for: Merck Sharp & Dohme; Novavax; Pfizer; Sanofi; Seqirus; Takeda; Valneva

Editor

Alessia Piazza, PhD

Medical Education Director, WebMD Global, LLC

Disclosures

Alessia Piazza, PhD, has no relevant financial relationships.

Compliance Reviewer

Amanda Jett, PharmD, BCACP

Associate Director, Accreditation and Compliance

Disclosures

Amanda Jett, PharmD, BCACP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

processing....

A Powerpoint version of the slides from this presentation
is available for use as a professional resource from Medscape Education.

Download Now

Activity Transcript

PDF Downloads

Patient Handout

Transcript Downloads

Print
Like Tweet

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred.

The material presented here does not necessarily reflect the views of WebMD, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been authorized by the European Medicines Agency for use in Europe, off-label uses of authorized products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Faculty

Federico Martinón-Torres, MD, PhD

George Kassianos, CBE, MD (Hons), FRCGP